Neuren Pharmaceuticals Limited(ASX:NEU) dropped from S&P/ASX Emerging Companies Index
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
19.06 AUD | -0.73% | -1.24% | -23.67% |
04-24 | Neuren Pharmaceuticals Posts AU$243 Million Cash, Short-Term Investments | MT |
04-23 | Neuren Pharmaceuticals' Medication Secures Priority Review from Health Canada | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-23.67% | 1.59B | |
+34.00% | 704B | |
+27.40% | 577B | |
-7.75% | 348B | |
+18.53% | 327B | |
+4.95% | 288B | |
+15.42% | 234B | |
+4.93% | 198B | |
-9.78% | 194B | |
-4.89% | 147B |
- Stock Market
- Equities
- NEU Stock
- News Neuren Pharmaceuticals Limited
- Neuren Pharmaceuticals Limited(ASX: NEU) dropped from S&P/ASX Emerging Companies Index